SMS Pharmaceuticals Limited 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | ₹295.60 |
| 52週高値 | ₹398.00 |
| 52週安値 | ₹113.30 |
| ベータ | 1.22 |
| 11ヶ月の変化 | -18.81% |
| 3ヶ月変化 | 5.61% |
| 1年変化 | 146.33% |
| 33年間の変化 | 102.88% |
| 5年間の変化 | 650.25% |
| IPOからの変化 | 722.83% |
最新ニュース
Recent updates
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40
Sep 07
SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be Increased To ₹0.40
Aug 22Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%
Aug 20SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40
Aug 08What SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 27% Share Price Gain Is Not Telling You
Jul 04Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Can Manage Its Debt Responsibly
Jun 21SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up
Feb 29SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment
Sep 24SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30
Sep 11SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 28SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet
Jun 07Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why
Sep 23SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30
Sep 15SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30
Sep 01SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 18We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt
Mar 22SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality
Jun 03Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?
Mar 08What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?
Feb 22The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It
Feb 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 18
Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Meaningful Debt Burden
Dec 09株主還元
| SMSPHARMA | IN Pharmaceuticals | IN 市場 | |
|---|---|---|---|
| 7D | 2.7% | 2.0% | 1.8% |
| 1Y | 146.3% | 58.6% | 36.8% |
業界別リターン: SMSPHARMA exceeded the Indian Pharmaceuticals industry which returned 58.6% over the past year.
リターン対市場: SMSPHARMA exceeded the Indian Market which returned 36.8% over the past year.
価格変動
| SMSPHARMA volatility | |
|---|---|
| SMSPHARMA Average Weekly Movement | 8.4% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 4.0% |
安定した株価: SMSPHARMA's share price has been volatile over the past 3 months compared to the Indian market.
時間の経過による変動: SMSPHARMA's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1987 | 1,197 | Ramesh Potluri | smspharma.com |
エス・エム・エス・ファーマシューティカルズ社は、医薬品原薬（API）とその中間体の製造・販売をインド国内外で行っている。抗レトロウイルス薬、抗炎症薬、抗ウイルス薬、抗糖尿病薬、抗真菌薬、抗てんかん薬、抗偏頭痛薬、抗凝固薬、抗精神病薬、抗狭心症薬、抗潰瘍薬などを提供している。また、ペプチドの受託研究活動も行っている。約75カ国に製品を輸出している。エス・エム・エス・ファーマシューティカルズ社は1987年に設立され、本社はインドのハイデラバードにある。
SMS Pharmaceuticals Limited 基礎のまとめ
| SMSPHARMA 基礎統計学 | |
|---|---|
| 時価総額 | ₹25.45b |
| 収益（TTM） | ₹569.64m |
| 売上高(TTM) | ₹7.38b |
43.9x
PER（株価収益率3.4x
P/SレシオSMSPHARMA は割高か？
公正価値と評価分析を参照収益と収入
| SMSPHARMA 損益計算書（TTM） | |
|---|---|
| 収益 | ₹7.38b |
| 売上原価 | ₹5.16b |
| 売上総利益 | ₹2.22b |
| その他の費用 | ₹1.65b |
| 収益 | ₹569.64m |
直近の収益報告
Jun 30, 2024
次回決算日
Nov 08, 2024
| 一株当たり利益（EPS） | 6.73 |
| グロス・マージン | 30.12% |
| 純利益率 | 7.71% |
| 有利子負債／自己資本比率 | 52.4% |
SMSPHARMA の長期的なパフォーマンスは？
過去の実績と比較を見る